Company news

InterCure Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow

April 30, 2026

InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement

March 3, 2026

InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Million

February 19, 2026

InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million

February 19, 2026

InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation

November 3, 2025

InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow

October 8, 2025

InterCure Announces Strategic Acquisition of ISHI, Unlocking Access to Premium U.S. Cannabis Technology and Brands

September 19, 2025

InterCure Announces FY2024 Results and Provides Q1 2025 Update: Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million, Strong Start to 2025

May 1, 2025

Calls

Decks